Connor Clark & Lunn Investment Management Ltd. Takes Position in Cigna Group $CI

Connor Clark & Lunn Investment Management Ltd. acquired a new position in Cigna Group (NYSE:CI) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 405,247 shares of the health services provider’s stock, valued at approximately $111,718,000.

Several other institutional investors have also added to or reduced their stakes in the stock. Wilkerson Advisory Group LLC bought a new position in Cigna Group during the 4th quarter worth approximately $25,000. Cedar Mountain Advisors LLC boosted its stake in shares of Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares during the last quarter. Johnson Financial Group Inc. bought a new stake in shares of Cigna Group in the 2nd quarter valued at $29,000. Kemnay Advisory Services Inc. acquired a new stake in shares of Cigna Group during the fourth quarter worth $29,000. Finally, Prosperity Bancshares Inc bought a new position in Cigna Group during the fourth quarter worth $29,000. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Price Performance

CI stock opened at $276.19 on Monday. The stock has a market capitalization of $72.98 billion, a PE ratio of 11.43, a price-to-earnings-growth ratio of 0.95 and a beta of 0.29. The company’s 50-day moving average is $284.20 and its 200-day moving average is $281.45. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The business had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm’s revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the company posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities research analysts expect that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group’s dividend payout ratio is presently 25.82%.

Analysts Set New Price Targets

Several research firms recently issued reports on CI. Wall Street Zen lowered shares of Cigna Group from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. The Goldman Sachs Group lifted their price objective on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Barclays upped their target price on Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Guggenheim lifted their target price on Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Finally, Wells Fargo & Company boosted their price target on Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the transaction, the insider directly owned 25,880 shares in the company, valued at approximately $7,236,306.80. This trade represents a 9.37% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 23,012 shares of company stock worth $6,386,550 in the last 90 days. 0.60% of the stock is currently owned by company insiders.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.